No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Disease Progression
-
Everolimus / adverse effects
-
Everolimus / therapeutic use*
-
Humans
-
Neurofibromatosis 2 / drug therapy*
-
Neuroma, Acoustic / drug therapy*
-
Treatment Outcome
-
Tumor Burden
Substances
-
Antineoplastic Agents
-
Everolimus